Judy Chou
SEC insider (Form 3/4/5 filer). CIK 0001871695. Director at Akero Therapeutics, Inc. (AKRO). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 9, 2025. Located in SOUTH SAN FRANCISCO, CA.
Companies Judy Chou has filed insider reports for
- Akero Therapeutics, Inc. (AKRO): Director
Judy Chou
CIK: 0001871695
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AKRO
Akero Therapeutics, Inc.
Director